We are live on ! Find out more
SP

Syncona Portfolio Portfolio holdings

AUM $25.7M
1-Year Est. Return 13.32%
This Fund
S&P 500
This Quarter Est. Return
+156.44%
1 Year Est. Return
+13.32%
3 Year Est. Return
+8.47%
5 Year Est. Return
10 Year Est. Return
AUM
$158M
AUM Growth
+$90.6M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUTL
1
Autolus Therapeutics
AUTL
$386M
$137M 87.15%
21,346,829
ACHL
2
DELISTED
Achilles Therapeutics
ACHL
$9.86M 6.25%
11,086,909
FRLN
3
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$9.33M 5.91%
1,466,507
ADAP
4
DELISTED
Adaptimmune Therapeutics
ADAP
$1.09M 0.69%
1,377,294

Similar funds

Syncona Portfolio's Q4 2023 Portfolio in Review

As of Q4 2023, Syncona Portfolio held 4 positions worth $158M, up 135% from $67.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 0%. Syncona Portfolio opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Syncona Portfolio's ten largest holdings make up 100% of its $158M portfolio in Q4 2023.
  • Syncona Portfolio opened 0 new positions and closed 0 in Q4 2023.
  • Syncona Portfolio's portfolio value rose 135% quarter-over-quarter to $158M.

Based on Syncona Portfolio's 13F filing for Q4 2023, filed 1 Feb 2024.